Ten months after taking over a state-of-the-art facility in New York that was expected to expand the company’s manufacturing footprint, ImmunityBio announced job cuts at the site.
https://www.pharmalive.com/wp-content/uploads/2022/10/BioSpacesadexecutive10-11-2022.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-10-11 11:02:372022-10-11 11:02:37ImmunityBio backslides while Rigel and Amneal also reveal job cuts
